Novogene

Novogene is a biotech company founded by Dr. Ruiqiang Li in 2011. It develops software for sequence mapping, variation detection, and genome assembly and has offices in Hong Kong, the United States and the United Kingdom.

Novogene is an Illumina Genome Network partner. They offer a range of NGS-based services for human, plant, animal and microbial DNA and RNA analysis.Services offered include human genome sequencing, gene regulation, single-cell sequencing, animal and plant solutions (such as genome sequencing), and microbial genome sequencing. Pharmaceutical companies can also utilize Novogene's technology for drug development related to insights gained from genomic sequencing. The technology at the company uses various systems, such as HiSeq X, to sequence genomes, which allows for the company to annually sequence 280,000 human genomes.

In its series B round of funding in 2016, Novogene raised $75 million.

Novogene, headquartered in Beijing with branches in Hong Kong, the U.S. and U.K., is a genomics solution provider with bioinformatics expertise and a large Illumina-based sequencing capacity in China.